REGISTERED NUMBER: 15979989 (England and Wales)

Unaudited Financial Statements for the Year Ended 30 September 2026

for

Elixir Medics Ltd

Page

Balance Sheet

1

Notes to the Financial Statements

3

Fixed assets

Tangible assets

4

25,288

19,718

Current assets

Debtors

5

98,735

970

Cash at bank

247,594

534

346,329

1,504

Creditors

Amounts falling due within one year

6

(288,457

)

(550

)

Net current assets

57,872

954

Total assets less current liabilities

83,160

20,672

Capital and reserves

Called up share capital

100

100

Retained earnings

7

83,060

20,572

Shareholders' funds

83,160

20,672

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 October 2026 and were signed on its behalf by:

Dr Sandeep Bansal - Director

Dr Rachna Bansal - Director

1.	Statutory information

Elixir Medics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

15979989

Registered office:

Marshall House, Suite 21-25

124 Middleton Road

Morden

Surrey

SM4 6RW

2.	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	Employees and directors

The average number of employees during the year was 4 (2025 - 2 ) .

4.	Tangible fixed assets

Fixtures

Plant and

and

machinery

fittings

Totals

£

£

£

Cost

At 1 October 2025

-

23,624

23,624

Additions

10,000

-

10,000

At 30 September 2026

10,000

23,624

33,624

Depreciation

At 1 October 2025

-

3,906

3,906

Charge for year

1,500

2,930

4,430

At 30 September 2026

1,500

6,836

8,336

Net book value

At 30 September 2026

8,500

16,788

25,288

At 30 September 2025

-

19,718

19,718

5.

Debtors: amounts falling due within one year

30.9.26

30.9.25

£

£

Trade debtors

94,450

880

Other debtors

90

90

Prepayments and accrued income

3,275

-

Prepayments

920

-

98,735

970

6.

Creditors: amounts falling due within one year

30.9.26

30.9.25

£

£

Corporation tax

39,845

-

Other creditors

246,812

550

Accrued expenses

1,800

-

288,457

550

7.

Reserves

Retained

earnings

£

At 1 October 2025

20,572

Profit for the year

116,705

Dividends

(54,217

)

At 30 September 2026

83,060